Lowest Price Guaranteed
Pages
194
Last Updated
June 2026
View Count
14096
The global novel spectrometry market, valued at USD 5.3 billion in 2025, is projected to reach USD 5.6 billion in 2026 and USD 12 billion by 2035, with a 8.7% CAGR during the forecast period 2026 to 2035.
To learn more about this report, request a free sample copy
Novel spectrometry refers to advancements in spectroscopy which is the study of the interaction between matter and electromagnetic radiation. In recent years, spectroscopy has become a crucial analytical tool for swiftly and accurately analyzing compounds across diverse industries such as food, biotechnology, pharmaceuticals, chemistry, material science, and environmental science. Spectroscopic instruments offer insights into electronic and optical properties, chemical composition, and crystallinity of substances. A diverse range of spectrometers are available in the market for instance, atomic absorption spectrometers, nuclear magnetic resonance (NMR), Raman spectrometers, and X-ray fluorescence (XRF) devices that are being utilized for qualitative and quantitative analyses. In addition, mass spectrometry stands out as the most popular technique due to its outstanding quantitative accuracy, coupled with liquid chromatography (LC/MS) and gas chromatography (GC/MS) for enhanced resolution.
 |
 |
 |
However, traditional spectrometers face several challenges including manual operation, leading to lower reproducibility and sensitivity. Novel spectrometers have emerged as a promising solution, showing potential in tackling these challenges. They offer many advancements such as automation, addressing issues of reproducibility and sensitivity. Furthermore, innovations such as miniaturization and portability have boosted the performance and throughput of novel spectrometers, making them even more attractive for analytical tasks.
 |
 |
 |
At present, around 160 novel spectrometry platforms have been developed by several key players in the global marketplace. Most market players are mid-sized companies serving in the market. Additionally, over the past few years, stakeholders have pursued numerous initiatives to enhance their intellectual property portfolios, filing over 3,000 patents for cutting-edge technologies and products boasting advanced features. Consequently, the rising adoption of novel spectrometry, expanding application industry, and increasing interest in advanced technology of market players, are the factors that are likely to accelerate the novel spectrometry market growth during this forecast period.
 |
 |
 |
The market research report presents an in-depth analysis of the various companies that are engaged in the global market of novel spectrometry instruments, across different segments, as defined in the table below:
| Key Report Attributes | Details | |
| Historical Trend | Since 2018 | |
| Forecast Period | Till 2035 | |
| Market Size in 2026 | USD 5.6 Billion | |
| Market Size in 2035 | USD 12 Billion | |
| CAGR (Till 2035) | 8.7% | |
| Type Of Spectrometers |
|
|
| By Company Size |
|
|
| Type of End-User |
|
|
| Key Geographical Regions |
|
|
| Key Companies Profiled | (A full list of operating companies captured is and available in the report) | |
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope |
15% Free Customization |
|
| Excel Data Packs (Complimentary) |
|
|
One of the key objectives of this market report was to estimate the current market size, opportunity, and future growth potential of this market , over the forecast period. Based on multiple parameters, likely adoption trends, and through primary validations, we have provided an informed estimate of the market evolution during the forecast period till 2035. The market report also features the likely distribution of the current and forecasted opportunity within the novel spectrometry industry across various segments, such as type of spectrometers (atomic absorption spectrometer, mass spectrometer, near-infrared spectrometer, nuclear magnetic resonance spectrometer, Raman spectrometer and x-ray fluorescence spectrometer), company size (small, mid-sized and large), end-user industry (agriculture/pesticide testing, environmental analysis, food biotechnology, forensic analysis, pharmaceutical analysis and other end users), and key geographical regions (North America, Europe and Asia Pacific, Latin America, Middle East, North Africa and rest of the world).
In order to account for future uncertainties and to add robustness to our model, we have provided three novel spectrometry market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s growth.
The opinions and insights presented in the market report were also influenced by discussions held with senior stakeholders in the industry. The market research report features detailed transcripts of interviews held with the following individuals:
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
The global market value is split across several types of spectrometers, such as Atomic Absorption Spectrometer, Mass Spectrometer, Near Infrared Spectrometer, Nuclear Magnetic Resonance Spectrometer, Raman Spectrometer, and X-Ray Fluorescence Spectrometer. Based on the types of spectrometers, mass spectrometers hold 92% of the novel spectrometry market share and are likely to be a dominating segment in the market. Nuclear Magnetic Resonance elevates the market growth at a CAGR of 11.0% over this forecast period. This growth can be ascribed to the growing research activities across various fields of pharmaceuticals, biotechnology, and environmental science, which require advanced analytical techniques like mass spectrometry for compound analysis.
Based on the type of company size, the novel spectrometry market is fragmented into Small, Mid-sized, and Large. In terms of revenue, large companies acquire 94% of the total market share and are projected to lift the market growth at a CAGR of 8.6%. Owing to the combination of strong R&D capabilities, expertise, higher investment, and positions large companies as a market leader through which they are shaping the market dynamics.
The novel spectrometers serves a diverse range of end-user industries such as Agriculture / Pesticide Testing, Environmental Analysis, Food Biotechnology, Forensic Analysis, Pharmaceutical Analysis, and Other End Users. Based on the type of end-user, pharmaceutical analysis acquires around 35.5% of the market share and is expected to drive the novel spectrometry market growth at a CAGR of 8.3%. The growth of this segment can be attributed to the extensive demand for novel spectrometry for several applications spanning drug development, quality control, regulatory compliance, and process optimization within the pharmaceutical industry.
This segment highlights the distribution of the global novel spectrometry market across various geographies, such as North America, Europe, and Asia-Pacific Latin America, Middle East and North Africa. According to our projections, North America leads the current market with the majority market share of 43%. Additionally, Asia Pacific is anticipated to escalate market growth with 8.8% CAGR during this projection period due to the emerging economy in developing nations such as China and India, significantly increasing their investments in research and development (R&D) across various industries, including pharmaceuticals, biotechnology, and environmental science, which in turn boosting the demand for advanced spectrometry technologies.
The “Novel Spectrometry Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market forecast and future opportunities for the companies involved in the market. Key takeaways of the market report are briefly discussed below.
Currently, numerous small, large, and mid-size companies are operating in the market for novel spectrometers. These companies are stimulating market growth by developing innovative novel spectrometry platforms. At present, around 160 novel spectrometry platforms have been developed by the leading market players across different geographical regions. Majority of the market players are mid-sized companies. However, large companies lead the novel spectrometry market with their cutting-edge technology.
Most of the companies based in North America have undertaken recent initiatives and established various partnerships and collaborations for several spectrometry technologies. Some of the prominent key players are Bruker, JEOL, Metrohm, PerkinElmer, Shimadzu, Thermo Fisher Scientific, and Waters. These companies adopt various business strategies to retain their market position. Growing strategic collaboration and partnership is a significant approach to expanding their portfolio. Close to 37.5% of intercontinental partnerships have occurred in the North American region. For instance, in June 2023, Seer (a life science proteomics firm) declared to extend its collaboration with Thermo Fisher Scientific to showcase its latest product, the Protocraph XT Assay Kit with the Thermo Scientific Orbitrap Astral mass spectrometer (MS)
With the latest trend of the increasing emphasis on miniaturization and portability, the novel spectrometry industry is evolving rapidly. By following this trend, companies are developing compact and portable spectrometers that offer high performance while being lightweight and easy to use. These portable spectrometers allow on-site analysis in various applications, including environmental monitoring, food safety, and healthcare diagnostics. Additionally, advancements in miniaturized components, such as microelectromechanical systems (MEMS) and nanotechnology, are driving the development of miniaturized spectrometry platforms with enhanced sensitivity and resolution. Along with this, the adoption of hybrid mass spectrometers highlights a significant trend in the market. Moreover, as the research continues to evolve and demand for advanced analytical solutions grows, the stakeholders are adopting different approaches in novel spectrometry emphasizing on proteomics and disease diagnostics. Moreover, hybrid mass spectrometers are expected to play an increasingly important role in driving innovation and enabling discoveries in analytical science which will likely generate lucrative opportunities for market players during this forecast period.
With regard to regional insights, North America dominates the novel spectrometry market with its largest market share. Various factors contribute to the region’s dominance in the global market for novel spectrometry. Firstly, nearly 30 big and small pharmaceutical /biotechnology companies are headquartered in North America. Their high investment in R&D for innovation in novel spectrometry technologies boosts the market growth. Along with advanced healthcare infrastructure, well-established end-user user industries significantly expand the demand for novel spectrometers. Additionally, North American stakeholders are undertaking the highest number of partnership and collaboration initiatives. For instance, recently, nearly 37.5% of partnerships occurred in North America and the majority of the deals were for acquisition and product development. Moreover, the rising number of global events for the novel spectrometer to expand opportunities for developers significantly contributed to the region’s leading position.
Examples of key companies engaged in the novel spectrometry industry (which have also been profiled in this market report; the complete list of companies is available in the full report) include Bruker, JEOL, Metrohm, PerkinElmer, Shimadzu, Thermo Fisher Scientific, and Waters. This market report includes an easily searchable excel database of all the companies developing spectrometer based on novel technologies.
A detailed assessment of the current market landscape of novel spectrometry platforms, featuring information on the type of spectrometer, software platform, type of technology used, type of detector, weight of spectrometer and type of end user industry. In addition, the chapter includes analysis of novel spectrometry manufacturers, along with information on their year of establishment, company size, location of headquarters and leading players (in terms of number of products being offered).
Several ongoing innovations and developments are projected to boost market potential. These developments, even if they took place post the release of our market report, substantiate the overall trends that have been outlined in our novel spectrometry market analysis.